Efficacy and Safety of Weekly Calcifediol Formulations (75 and 100 µg) in Subjects with Vitamin D Deficiency: A Phase II/III Randomised Trial
New weekly calcifediol 75 and 100 µg formulations showed an effective and sustained response with a good long-term safety profile.
Authors
- José-Luis Pérez-Castrillón (ORCID: https://orcid.org/0000-0002-1723-217X)
- Paula Arranz
- Dimitar B. Nikolov (ORCID: https://orcid.org/0000-0001-8774-5061)
- Inmaculada Gilaberte (ORCID: https://orcid.org/0000-0002-3811-9811)
- Snežana Novković
- Umberto Tarantino (ORCID: https://orcid.org/0000-0003-0330-2189)
- Aintzane García‐Bea
- Esteban Jódar (ORCID: https://orcid.org/0000-0002-1234-8560)
- Nadia Mehsen-Cêtre
- Ján Nociar
- Cristina Martínez Ostalé
- Michal Lojka
- Fernando Cereto-Castro
Institutions
- Hospital Universitario Quirónsalud Madrid (ES)
- Hôpital Pellegrin (FR)
- Hospital Quirónsalud Barcelona (ES)
- Policlinico Tor Vergata (IT)
- Faes Farma (Spain) (ES)
- Hospital Universitario Río Hortega (ES)
Publication Details
- Journal
- Nutrients
- Published
- 2024-11-05
- DOI
- https://doi.org/10.3390/nu16223796
- Citations
- 2
- Primary Topic
- Vitamin D Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.85